Literature DB >> 16281057

SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.

Jun Huang1, Ting Liu, Liang-Guo Xu, Danying Chen, Zhonghe Zhai, Hong-Bing Shu.   

Abstract

Viral infection or TLR3 engagement causes activation of the transcription factors IRF-3 and NF-kappaB, which collaborate to induce transcription of type I IFN genes. IKKepsilon and TBK1 are two IKK-related kinases critically involved in virus- and TLR3-triggered activation of IRF-3. We identified a protein termed SIKE (for Suppressor of IKKepsilon) that interacts with IKKepsilon and TBK1. SIKE is associated with TBK1 under physiological condition and dissociated from TBK1 upon viral infection or TLR3 stimulation. Overexpression of SIKE disrupted the interactions of IKKepsilon or TBK1 with TRIF, RIG-I and IRF-3, components in virus- and TLR3-triggered IRF-3 activation pathways, but did not disrupt the interactions of TRIF with TRAF6 and RIP, components in TLR3-triggered NF-kappaB activation pathway. Consistently, overexpression of SIKE inhibited virus- and TLR3-triggered interferon-stimulated response elements (ISRE) but not NF-kappaB activation. Knockdown of SIKE potentiated virus- and TLR3-triggered ISRE but not NF-kappaB activation. Moreover, overexpression of SIKE inhibited IKKepsilon- and TBK1-mediated antiviral response. These findings suggest that SIKE is a physiological suppressor of IKKepsilon and TBK1 and plays an inhibitory role in virus- and TLR3-triggered IRF-3 but not NF-kappaB activation pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16281057      PMCID: PMC1356304          DOI: 10.1038/sj.emboj.7600863

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  ZNF216 Is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation.

Authors:  Jun Huang; Lin Teng; Lixia Li; Ting Liu; Lianyun Li; Danying Chen; Liang-Guo Xu; Zhonghe Zhai; Hong-Bing Shu
Journal:  J Biol Chem       Date:  2004-01-30       Impact factor: 5.157

2.  RIGging an antiviral defense--it's in the CARDs.

Authors:  David E Levy; Isabelle J Marié
Journal:  Nat Immunol       Date:  2004-07       Impact factor: 25.606

3.  Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.

Authors:  Ke-Jun Han; Xiaoqin Su; Liang-Guo Xu; Liang-Hua Bin; Jun Zhang; Hong-Bing Shu
Journal:  J Biol Chem       Date:  2004-01-22       Impact factor: 5.157

4.  Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection.

Authors:  Kenya Honda; Shinya Sakaguchi; Chigusa Nakajima; Ai Watanabe; Hideyuki Yanai; Misako Matsumoto; Toshiaki Ohteki; Tsuneyasu Kaisho; Akinori Takaoka; Shizuo Akira; Tsukasa Seya; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

5.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

6.  RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation.

Authors:  Etienne Meylan; Kim Burns; Kay Hofmann; Vincent Blancheteau; Fabio Martinon; Michelle Kelliher; Jürg Tschopp
Journal:  Nat Immunol       Date:  2004-04-04       Impact factor: 25.606

7.  Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.

Authors:  Shintaro Sato; Masanaka Sugiyama; Masahiro Yamamoto; Yasuyuki Watanabe; Taro Kawai; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

8.  Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.

Authors:  Zhengfan Jiang; Tak W Mak; Ganes Sen; Xiaoxia Li
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

9.  The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection.

Authors:  Hiroaki Hemmi; Osamu Takeuchi; Shintaro Sato; Masahiro Yamamoto; Tsuneyasu Kaisho; Hideki Sanjo; Taro Kawai; Katsuaki Hoshino; Kiyoshi Takeda; Shizuo Akira
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

10.  Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection.

Authors:  Andrea K Perry; Edward K Chow; Julia B Goodnough; Wen-Chen Yeh; Genhong Cheng
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

View more
  63 in total

1.  A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.

Authors:  Suzanne Paz; Myriam Vilasco; Steven J Werden; Meztli Arguello; Deshanthe Joseph-Pillai; Tiejun Zhao; Thi Lien-Anh Nguyen; Qiang Sun; Eliane F Meurs; Rongtuan Lin; John Hiscott
Journal:  Cell Res       Date:  2011-01-04       Impact factor: 25.617

Review 2.  STRIPAK complexes in cell signaling and cancer.

Authors:  Z Shi; S Jiao; Z Zhou
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

3.  TBK1-associated protein in endolysosomes (TAPE) is an innate immune regulator modulating the TLR3 and TLR4 signaling pathways.

Authors:  Chun-Hung Chang; Li-Chun Lai; Hung-Chi Cheng; Kuan-Ru Chen; Ying-Zhang Syue; Hsueh-Chi Lu; Wan-Ying Lin; Shun-Hua Chen; Huei-Sheng Huang; Ai-Li Shiau; Huan-Yao Lei; Jun Qin; Pin Ling
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

4.  Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists.

Authors:  Joseph E Henriquez; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2019-02-23       Impact factor: 4.219

5.  An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture.

Authors:  James M Holaska; Katherine L Wilson
Journal:  Biochemistry       Date:  2007-07-10       Impact factor: 3.162

6.  Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase.

Authors:  Feici Diao; Shu Li; Yang Tian; Min Zhang; Liang-Guo Xu; Yan Zhang; Rui-Peng Wang; Danying Chen; Zhonghe Zhai; Bo Zhong; Po Tien; Hong-Bing Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-28       Impact factor: 11.205

7.  NLRX1: friend or foe?

Authors:  Etienne Meylan; Jürg Tschopp
Journal:  EMBO Rep       Date:  2008-03       Impact factor: 8.807

8.  The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation.

Authors:  Jian Wu; Lu Xia; Xiangyu Yao; Xiao Yu; Keyla C Tumas; Wenxiang Sun; Yang Cheng; Xiao He; Yu-Chih Peng; Brajesh K Singh; Cui Zhang; Chen-Feng Qi; Silvia Bolland; Sonja M Best; Channe Gowda; Ruili Huang; Timothy G Myers; Carole A Long; Rong-Fu Wang; Xin-Zhuan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-30       Impact factor: 11.205

9.  WDR5 is essential for assembly of the VISA-associated signaling complex and virus-triggered IRF3 and NF-kappaB activation.

Authors:  Yan-Yi Wang; Li-Juan Liu; Bo Zhong; Tian-Tian Liu; Ying Li; Yan Yang; Yong Ran; Shu Li; Po Tien; Hong-Bing Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 10.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.